
Dermata Therapeutics, Inc. has raised $12.7M in total funding. The most recent round was Series E.
Dermata Therapeutics, Inc. is headquartered in San Diego, CA.
Consumers want high-quality, scientifically proven skincare products that let them manage their skin health independently and simplify their routine.
Dermata is shifting to developing and distributing scientifically backed, direct-to-consumer skincare products, starting with a once-weekly skin renewal kit.
It positions itself as a scientific leader in dermatologic solutions offering natural, science-backed formulations rather than typical consumer skincare.
Founder and CEO Gerald Proehl previously led Santarus Inc. through its $2.6 billion sale to Salix Pharmaceuticals.
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 27, 2026.